Which kidney test is more accurate? new study aims to find out

NCT ID NCT06797609

Ongoing Knowledge-focused Sponsor: Mario Negri Institute for Pharmacological Research Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This observational study compares two common blood tests—creatinine and cystatin C—to see which one better estimates actual kidney function in people with nephrotic syndrome. Researchers will use stored blood samples from 50 participants in three ongoing clinical trials. The goal is to improve how doctors monitor kidney health in this condition.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors choose the most accurate blood test to measure kidney function in people with nephrotic syndrome, leading to better monitoring.
What could go wrong: This is a small, observational study using stored samples, not a treatment trial. It may not change practice directly, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEPHROTIC SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

idiopathic membranous glomerulonephritis nephrotic syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NEPHROTIC SYNDROME

Contacts and locations

Locations

ASST Papa Giovanni XXIII

Bergamo, BG, 24027, Italy
Centro di Ricerche Cliniche per le Malattie Rare Aldo e Cele Daccò

Ranica, BG, 24020, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.